MedUni Vienna researchers discover possible trigger of chronic inflammatory bowel disease

As the cause of chronic inflammatory bowel diseases (IBD) such as Crohn’s disease or ulcerative colitis is not yet known, treatment for sufferers is currently aimed at alleviating the often agonizing symptoms.

SEBASTIAN BRAUN WINS EY ENTREPRENEUR OF THE YEAR – Biotech Investments

EQS-News: Cheplapharm AG / Key word(s): Miscellaneous SEBASTIAN BRAUN WINS EY ENTREPRENEUR OF THE YEAR 08.11.2024 / 10:45 CET/CEST The issuer is solely responsible for

November 9, 2024

European Medicines Agency CMO Talks Psychedelics and Their Therapeutic Use in Live Q&A – Psychedelic Alpha

On Tuesday, Dr. Steffen Thirstrup, Chief Medical Officer (CMO) of the European Medicines Agency (EMA), gave a live presentation and Q&A on the topic of ‘psychedelics and

May 9, 2024

Takeda shells out $100m to license AC Immune’s Phase II Alzheimer’s therapy

AC Immune’s ACI-24.060 is designed to induce an antibody response against the toxic forms of amyloid beta thereby disrupting plaque formation and disease progression in

May 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.